Omeros | OMER - Market Capitalization


Omeros reported $937.3M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
BioMarin Pharmaceutical USD 10.57B 290M May/2026
Cytokinetics USD 9.1B 909M May/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
MacroGenics USD 102M 4M Dec/2025
Pacira USD 915M 149M Mar/2026
Pfizer USD 149.77B 4.04B May/2026
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 111.03B 2.55B May/2026